Search Results

Containing any of the words

Only of the type

Netupitant and palonosetron fixed-dose combination versus 5-HT3 receptor antagonists in preventing chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy: A randomized, open-label, phase IV trial Drug Clinical Trial

Prince Fahd bin Sultan Sponsors the 7th International Saudi Pharmaceutical Conference News

French health authorities ban cosmetics containing vitamin K1 (phytonadione) Warnings

Health Canada advises consumers not to use Liviro3 dietary supplement due to potential health risks Warnings

SFDA Reports Growth in Registration and Licensing During Q1 2024 News

Mid-annual PV Inspection Report 2024 Awareness Article

Aminotransferase Elevations in Healthy Adults Receiving 4 Grams of Acetaminophen Daily Awareness Article

Arsenic Exposure and Prevalence of Type 2 Diabetes in US Adults Awareness Article

SFDA Captures 6 tons of violating honey, rice, fish and cheese in Dammam & Bisha Warnings

SFDA’s Drug Sector Holds its 2nd, Annual Gathering News